SecondWave

SecondWave Systems is a pioneer in the emerging field of bio-ultrasound medicine. The company is developing a first-of-its-kind non-invasive wearable ultrasound stimulation platform, offering new treatment options for patients and their doctors to address debilitating or life-threatening conditions. The company's SecondWave MINI™ device utilizes proprietary low-intensity focused ultrasound technology to stimulate the spleen, with the aim of treating acute and chronic inflammatory diseases. Clinical research on this technology is currently underway to reduce acute inflammation in COVID-19, and additional studies are planned to explore its use in chronic inflammatory conditions such as rheumatoid arthritis.